Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19.

McPherson, Scott W; Keunen, Jan E; Bird, Alan C; Chew, Emily Y; van Kuijk, Frederik J

McPherson, Scott W; Keunen, Jan E; Bird, Alan C; Chew, Emily Y; van Kuijk, Frederik J.

McPherson SW; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA.
Keunen JE; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Bird AC; Moorfields Eye Hospital, London, United Kingdom.
Chew EY; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
van Kuijk FJ; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: vankuijk@umn.edu.

Am J Ophthalmol ; 216: A5-A6, 2020 08.

Article in English | MEDLINE | ID: covidwho-377959

Subject(s)

Betacoronavirus/drug effects; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Zinc Compounds/administration & dosage; Administration, Oral; Angiotensin-Converting Enzyme 2; Antiviral Agents/administration & dosage; COVID-19; Clinical Trials as Topic; Enzyme Inhibitors/administration & dosage; Humans; Peptidyl-Dipeptidase A/drug effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Zinc Compounds / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Ophthalmol Year: 2020 Document Type: Article Affiliation country: J.ajo.2020.04.028

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google